Close Brothers backs €137m pharma buyout

Close Brothers Private Equity, a UK mid-market buyout firm, has made its first direct investment in the pharmaceuticals sector with a $176m management buyout of Rosement Pharmaceuticals, a developer of off-patent oral liquid medicines.